• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting

    10/12/22 8:45:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care
    Get the next $SYK alert in real time by email

    Newly Launched Q Guidance System with Spine Guidance Software Receives 2022 Spine Technology Award

    Stryker (NYSE:SYK), one of the world's leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society (NASS) annual meeting in Chicago, Oct. 12–15 (booth #4211).

    "Our expanding portfolio of differentiated spinal procedural innovations demonstrates our commitment to bringing state-of-the-art technology to surgeons and their patients," said Robbie Robinson, President of the Spine division, Stryker. "This has been an exciting year with several new products launched, signifying the continued growth of our Spine business. We are thrilled to reconnect with current and make the acquaintance of future customers as well as showcase our newest additions at NASS."

    The Company will highlight legacy solutions along with several newly launched products, which include:

    • Q Guidance System with Spine Guidance Software combines a redesigned, fourth generation FP8000 camera with an intuitive user interface and sophisticated algorithms to deliver more surgical spine planning and navigation capability than ever before. The Q Guidance System is the hub of Stryker's fully integrated ecosystem, driving more value for its customers. With a robust product pipeline in place that will include Cranial Guidance Software*, Stryker is positioned to provide a well-rounded, end-to-end guidance platform for its surgeon customers. The Company is also currently developing the Mako robotic technology for spinal application that is intended to integrate with its navigation technology**. During the meeting, the Q Guidance System with Spine Guidance Software will be awarded the 2022 Best Technology in Spine by Orthopedics This Week, which recognizes excellence in innovation for the year's best new technologies, along with their engineering teams and inventors.
    • Monterey® AL Interbody System is a stand-alone interbody fusion device designed for anterior lumbar interbody fusion. The System is the latest cage built using Tritanium In-Growth Technology and is validated by newly presented pre-clinical data demonstrating that undifferentiated stem cells grown on Tritanium exhibited osteogenic Alkaline Phosphatase without requiring growth factor supplements.1,2
    • Bone Mill+™ features an enhanced power base, a new bone mill that can produce 46% more bone yield, 99 times faster compared to manual milling, and a new disposable cartridge for automated tissue removal that is 2.5 times faster than manual tissue removal.3
    • OmniCurve™ is a curved balloon system built on the strength of AVAflex balloon system and designed to enhance the user's capabilities and control. Enabling a one-handed technique, it is designed to reach midline every time and offers unipedicular access with bipedicular results.4

    Stryker will showcase its portfolio of spine solutions at NASS (booth #4211), including a chance to experience the technologies hands-on during a Surgical Stadium event taking place Friday, October 14, from 10:45 a.m.–12:00 p.m. in the Technical Exhibition McCormick Place, West Building, with proctors Drs. Shah Dodwad and Griffin R. Baum.

    *Cranial Guidance Software has not yet received 510(k) clearance to market.

    **Mako for spine applications is not available for sale.

    About Stryker

    Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, and Orthopaedics and Spine that help improve patient and hospital outcomes. Alongside its customers around the world, Stryker impacts more than 100 million patients annually. More information is available at www.stryker.com.

    References:

    1. Stryker data on file; RD 62430 Tritanium hMSC osteogenic differentiation.

    2. Reza, A. et al. "Randomized porous titanium impacts cell morphology and induces stem cell differentiation in vitro." Orthopaedic Research Society 5th International Spine Research Symposium, 2019, 5: 83.

    3. Stryker data on file (10-minute Bone Mill+ cycle vs 10 minutes of manual soft tissue removal)

    4. Stryker data on file (Based on fill volume)

    CONTENT ID: QGS-MM-2_3426

    View source version on businesswire.com: https://www.businesswire.com/news/home/20221012005482/en/

    Get the next $SYK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYK

    DatePrice TargetRatingAnalyst
    1/27/2026$387.00Hold
    TD Cowen
    1/6/2026$418.00Mkt Perform → Outperform
    Raymond James
    12/19/2025$440.00Mkt Perform → Mkt Outperform
    Citizens JMP
    9/18/2025$420.00Neutral
    Rothschild & Co Redburn
    2/26/2025$450.00Buy
    Citigroup
    12/2/2024$370.00 → $445.00Equal-Weight → Overweight
    Morgan Stanley
    9/10/2024$405.00Outperform
    Wolfe Research
    5/30/2024$372.00Neutral
    Goldman
    More analyst ratings

    $SYK
    SEC Filings

    View All

    Stryker Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - STRYKER CORP (0000310764) (Filer)

    1/29/26 4:11:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - STRYKER CORP (0000310764) (Filer)

    12/4/25 4:16:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Stryker Corporation

    144 - STRYKER CORP (0000310764) (Subject)

    11/14/25 4:27:05 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 15

    2/4/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports 2025 operating results and 2026 outlook

    Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        17.5        %         0.9        %         16.6        %         4.0        %         12.6        %

    1/29/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker

    Deal expands global manufacturing footprint and positions VB Spine for future growth in spine care VB Spine LLC ("VB Spine") today completed the acquisition of Stryker's spine implant manufacturing facility in Cestas, France. Known for its state-of-the-art operations and technical capabilities, the Cestas facility will play a central role in VB Spine's global manufacturing strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106463289/en/VB Spine's manufacturing facility in Cestas, France This milestone expands on the April 1, 2025 formation of VB Spine, established through the acquisition of Stryker's U.S. spine implan

    1/6/26 8:57:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen resumed coverage on Stryker with a new price target

    TD Cowen resumed coverage of Stryker with a rating of Hold and set a new price target of $387.00

    1/27/26 8:50:06 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker upgraded by Raymond James with a new price target

    Raymond James upgraded Stryker from Mkt Perform to Outperform and set a new price target of $418.00

    1/6/26 8:28:26 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Stryker from Mkt Perform to Mkt Outperform and set a new price target of $440.00

    12/19/25 8:42:48 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stryker Ronda E sold $181,719,269 worth of shares (500,000 units at $363.44) (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    2/6/26 6:21:06 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VP, Chief Accounting Officer Berry William E Jr was granted 797 shares, increasing direct ownership by 28% to 3,602 units (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    2/6/26 5:53:59 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by VP, Chief Comm. Officer Montagnino Kimberly Ann

    4 - STRYKER CORP (0000310764) (Issuer)

    2/6/26 5:49:19 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Financials

    Live finance-specific insights

    View All

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30, 2026, to shareholders of record at the close of business on March 31, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 15

    2/4/26 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports 2025 operating results and 2026 outlook

    Portage, Michigan, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2025: Fourth Quarter Results Reported net sales increased 11.4% to $7.2 billionOrganic net sales increased 11.0%Reported operating income margin of 25.2%Adjusted operating income margin(1) increased 100 bps to 30.2%Reported EPS increased 56.0% to $2.20Adjusted EPS(1) increased 11.5% to $4.47  Fourth Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        17.5        %         0.9        %         16.6        %         4.0        %         12.6        %

    1/29/26 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker

    Deal expands global manufacturing footprint and positions VB Spine for future growth in spine care VB Spine LLC ("VB Spine") today completed the acquisition of Stryker's spine implant manufacturing facility in Cestas, France. Known for its state-of-the-art operations and technical capabilities, the Cestas facility will play a central role in VB Spine's global manufacturing strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106463289/en/VB Spine's manufacturing facility in Cestas, France This milestone expands on the April 1, 2025 formation of VB Spine, established through the acquisition of Stryker's U.S. spine implan

    1/6/26 8:57:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/14/23 12:37:55 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/10/23 9:18:16 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    3/11/25 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Kadant Set to Join S&P SmallCap 600

    NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE:KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE:SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name      Action Company Name Ticker GICS Sector February 19, 2025 S&P SmallCap 600 Addition Kadant KAI Industrials February 19, 2025 S&P SmallCap 600 Deletion Inari Medical NARI Health Care For more information about

    2/13/25 5:54:00 PM ET
    $KAI
    $NARI
    $SPGI
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer

    Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein's decision follows an impressive 22-year career at Stryker. Preston Wells, who currently serves as Group CFO for Stryker's Orthopaedics Group, will assume the role of Vice President, Chief Financial Officer effective April 1, 2025. "I want to thank Glenn for his performance drive, strong business partnership, and excellent leadership of the Finance and IT organizations. Glenn is a growth champion who invested in developing talent, including Preston Wells, who has been promoted to Chief Financial Offi

    1/28/25 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care